Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Enliven Therapeutics, Inc. (ELVN) had Return on Assets of -21.78% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-103.69M |
|
-- |
|
-- |
|
$119.66M |
|
$-119.66M |
|
$15.96M |
|
$-103.69M |
|
$-103.69M |
|
$-103.69M |
|
$-103.69M |
|
$-103.69M |
|
$-103.69M |
|
$-119.66M |
|
$-119.62M |
|
56.66M |
|
56.66M |
|
$-1.83 |
|
$-1.83 |
|
| Balance Sheet Financials | |
$474.88M |
|
$0.03M |
|
$1.29M |
|
$476.17M |
|
$16.57M |
|
-- |
|
-- |
|
$16.57M |
|
$459.60M |
|
$459.60M |
|
$459.60M |
|
59.44M |
|
| Cash Flow Statement Financials | |
$-70.30M |
|
$-173.84M |
|
$218.87M |
|
$124.17M |
|
$98.90M |
|
$-25.27M |
|
$34.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-70.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-22.56% |
|
-22.56% |
|
|
Return on Assets |
-21.78% |
-22.56% |
|
$7.73 |
|
$-1.24 |
|
$-1.24 |
|